Travelers Face Greater Risk of Leg Clots

... Known as deep vein thrombosis (DVT) or venous thromboembolism (VTE), this serious condition can sometimes lead ... Dr. Samuel Z. Goldhaber, director of the Venous thromboembolism Research Group in the cardiovascular division of ... Medical School, Boston, and director, Venous thromboembolism Research Group, cardiovascular division, Brigham ...

For Prevention of Stroke, Surveyed Cardiologists and PCPs Expect to Prescribe Xarelto to Approximately One-Third of Newly-Diagnosed Atrial Fibrillation Patients

... report entitled Novel Anticoagulants for Venous thromboembolism and Stroke Prevention in Atrial Fibrillation: ... for stroke prevention and heparins for venous thromboembolism prevention (VTE), both drug classes have ... alone. Novel Anticoagulants for Venous thromboembolism and Stroke Prevention in Atrial Fibrillation: ...

Surveyed Experts Indicate That Xarelto Has Advantages Over Lovenox in the Treatment of Venous Thromboembolism in Medically Ill Patients

... a therapy's effect on the prevention of venous thromboembolism (VTE) is the attribute that most influences their ... the market. The new report entitled Venous thromboembolism Prophylaxis in Medically Ill Patients: ... over Lovenox." About the Report Venous thromboembolism Prophylaxis in Medically Ill Patients: ...

Research highlights new approaches to prevent blood clots

... as venous thromboembolism. "Venous thromboembolism is a serious public health problem that affects ... to that of the placebo group. Venous thromboembolism occurred 11 times in both the nadroparin and ... with idraparinux. Rates of recurrent venous thromboembolism (2.3 percent versus 3.2 percent) and fatal or ...

Transfusions increase clot risk in hospitalized cancer patients

... , pose a quandary for doctors who want to prevent thromboembolism one of the leading causes of illness and death ... those patients, 7.2 percent developed venous thromboembolism (VTE) and 5.2 percent developed arterial thromboembolism (ATE.) That's significantly higher than the 3.8 ...

Drugs used for cancer-associated anemia linked with increased risk of blood clots, death

... is associated with an increased risk of venous thromboembolism (blood clots in the deep veins of the legs or in ... that there may be a higher risk of venous thromboembolism (VTE) with these medications, but it has not been ... ESA vs. the control (placebo) group. Venous thromboembolism was evaluated for 38 trials that included 8,172 ...

In-Flight Clot Risk Low for Most People

... Medical Center, The Netherlands. Venous thromboembolism is a condition where blood clots form in the ... Harvard Medical School and director of the Venous thromboembolism Research Group at Brigham and Women's Hospital in ... "is a tiny risk compared with the risk of venous thromboembolism from obesity, severe medical illness, cancer, or ...

New study suggests Rx estrogen delivery through the skin may show safety benefits as opposed to oral delivery

... therapy available by prescription "seems not to alter" the risk of venous thromboembolism (VTE), or blood clotting, in postmenopausal patients when compared to oral ... that oral, not transdermal estrogen may increase the risk of venous thromboembolism in postmenopausal women." ...

Eisai Inc. and the North American Thrombosis Forum (NATF)* Introduce the DVTeamCare(TM) Hospital Award and Call for Nominations

... Eisai Inc. "As the Acting Surgeon General's Call to Action on Venous thromboembolism (VTE) gets underway, we are pleased to be working with the NATF to ... hospitals enhance their efforts to prevent DVT. "Fatal Venous thromboembolism (VTE) may be the most common preventable cause of hospital death in the ...

Transfusing Anemic Cancer Patients Boosts Clot Risk

... from 1995 to 2003. Of those patients, 7.2 percent developed venous thromboembolism (VTE), and 5.2 percent developed arterial thromboembolism (ATE), compared with rates of 3.8 percent and 3.1 percent, respectively, ...

Cancer Drug Ups Risk of Clots in Veins

... it resulted in similar problems in veins, a condition known as venous thromboembolism (VTE). The new research, published in the Nov. 19 issue of the Journal ... Center, N.Y., and member, American Society of Clinical Oncology's Venous thromboembolism Guidelines Panel; Nov. 19, 2008, Journal of the American Medical ...

Statins Lower Risk of Clots in Cancer Patients

... Study found those who took them were less likely to get venous thromboembolism MONDAY, Oct. 27 (HealthDay News) -- A class of drugs widely ... thrombosis and would not be expected to help venous thrombosis." Venous thromboembolism (VTE) is a condition that includes deep vein thrombosis (DVT) as well as ...

Rivaroxaban phase III pivotal data presented at EFORT annual meeting

... significant 31% relative risk reduction (RRR) in total venous thromboembolism (VTE) events defined in the study as the composite of all deep vein ... did not reach statistical significance. Unmet Needs in Venous thromboembolism (VTE) Annually in the U.S., more than 900,000 people suffer from VTE ...

Clot-Busting Drug Offers New Approach to DVT

... over the long term," said Dr. Samuel Z. Goldhaber, director of the venous thromboembolism research group at Brigham and Women's Hospital in Boston. Goldhaber ... School of Medicine, St. Louis; Samuel Z. Goldhaber, M.D., director, venous thromboembolism research group, Brigham and Women's Hospital, Boston; February 2008 ...

New Anticoagulant Pill Works Well in Trial

... Rivaroxaban is a pill that blocks factor Xa, which is involved in blood clotting. In earlier studies, the drug was effective in preventing venous thromboembolism (blood clots in the legs) after orthopedic surgery, although some increased risk in bleeding episodes was seen. In this phase II trial, researchers ...

Quality measures improve outcomes more than hospital volume alone

... site infection on the operative day, whether the antimicrobial was appropriate, whether serial compression devices were used to prevent venous thromboembolism on the operative day, and whether aspirin, beta-blockers, or statin lipid-lowering drugs were administered in the first two days after surgery. ...

NCCN Updates Supportive Care Guidelines for VTE

... and academic settings. The NCCN Guidelines for Venous Thromboembolic Disease are one of the NCCN Guidelines for Supportive Care. Venous thromboembolism (VTE), commonly known as "economy class syndrome," includes both deep venous Thrombosis (DVT) and pulmonary embolism (PE), and is a common and ...

New Approach to Progesterone Supplementation in ART Revealed in Recently Published White Paper

... in ENDOMETRIN(R); a known missed abortion or ectopic pregnancy; liver disease; known or suspected breast cancer; active arterial or venous thromboembolism or severe thrombophlebitis, or a history of these events. About Ferring Pharmaceuticals Ferring Pharmaceuticals, part of the Ferring Group, ...

Journal Chest: April news briefs

... of 7,264 patients who underwent podiatric surgical procedures. Of the 16,804 total procedures recorded, overall incidence of post-procedure venous thromboembolism (VTE) was 0.30 percent. The incidence of VTE increased slightly with the presence of risk factors, including prior VTE, use of hormone replacement ...

DecisionBase 2009 Now Available from Decision Resources

... Angina) NSTEMI (Non-ST-Elevated Myocardial Infarction) STEMI (ST-Elevated Myocardial Infarction) Venous thromboembolism CNS Alzheimer's Disease (Mild-to-Moderate) ...

Video: CRESTOR(R) Reduced Risk of Blood Clots in the Veins

... -- A new analysis from the JUPITER study shows that CRESTOR(R) (rosuvastatin calcium) 20mg significantly cut the risk of venous thromboembolism (VTE) by 43% (p =0.007) compared to placebo among men and women with low to normal cholesterol levels and elevated high-sensitivity C-reactive ...

Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date

... in over 38,000 patients. In addition to RE-LY(R), the development program encompasses studies in: Primary prevention of venous thromboembolism (VTE) Treatment of acute VTE Secondary prevention of VTE Prevention of cardiac events in patients with acute coronary ...

Journal Chest: March news briefs

... PE was 19.9 percent, but this increased to 24.7 percent in patients with COPD who were hospitalized for acute exacerbations. The prevalence of venous thromboembolism risk factors also was higher among patients requiring hospitalization compared with patients treated in the emergency department. Researchers ...

ESC reaffirms advice on cardiovascular risks associated with long-haul flights

... of the medical issues associated with commercial air travel, the European Society of Cardiology has reaffirmed its advice about the risks of venous thromboembolism (VTE), whose risk, according to The Lancet , is increased "up to four-fold" by long-haul flight. Dr Steen Kristensen, Vice-president of the ESC, ...

Study shows optimal dose management of warfarin improves anticoagulation control

... online in the December 2008 issue of the Journal of Thrombosis and Haemostasis . Warfarin is highly effective to prevent strokes, treat venous thromboembolism and for other conditions. Numerous studies have focused on the underutilization of warfarin for patients with atrial fibrillation, the most common ...

Daiichi Sankyo, Inc. Announces Three Studies of Oral Factor Xa Inhibitor DU-176b Accepted for the 50th Annual Meeting of the American Society of Hematology

... Double-Blind, Multi-Dose Efficacy, Safety and Biomarker Study of the Oral Factor Xa Inhibitor DU-176b Compared with Placebo for Prevention of Venous thromboembolism in Patients After Total Knee Arthroplasty (Abstract 34), by Takashi Fuji, MD, Department of Orthopaedic Surgery, Osaka Koseinenkin Hospital, Osaka, ...

Flu Shots Lower Risk of Blood Clots

... medicine at the University of California, San Francisco, said during a news conference on Sunday. "It's another nail to hammer on." Venous thromboembolism (VTE) refers to the development of a blood clot in a vein. Such a clot can be life-threatening if breaks off and travels to the lung (pulmonary ...

Statins show promise for blood clot prevention

... College of Chest Physicians (ACCP), suggests that the use of statins may be associated with a significant reduction in the occurrence of venous thromboembolism (VTE), a condition that includes DVT and pulmonary embolism, in patients with solid organ tumors, including breast, lung, and colon cancers. "The ...

Statins Show Promise for Blood Clot Prevention

... College of Chest Physicians (ACCP), suggests that the use of statins may be associated with a significant reduction in the occurrence of venous thromboembolism (VTE), a condition that includes DVT and pulmonary embolism, in patients with solid organ tumors, including breast, lung, and colon cancers. "The ...

Migraine Sufferers Face Greater Blood Clot Risk

... on its head by suggesting that a migraine diagnosis raises the risk for such potentially fatal clotting incidents -- known as venous thrombosis or thromboembolism -- while having little or no impact on the risk for developing any hardening or narrowing of the arteries. "Our study refutes the widespread view ...

Afid Therapeutics Inc.'s New Anticoagulant Heparin Replacement Passes in Vivo Test

... Its many uses include the treatment of acute deep venous thrombosis and pulmonary embolism. It is also used to prevent the occurrence of venous thromboembolism in some patients. Two other important other uses of heparin are as adjuncts in dialysis to prevent clotting and to prevent intravascular ...

Oral Drug Helps Prevent Clotting After Hip Replacement

... the oral drug rivaroxaban helps prevent potentially fatal blood clots after hip replacement surgery, British researchers say. The risk of venous thromboembolism (VTE) is high after total hip replacement, and the risk can persist after a patient leaves hospital. Current guidelines recommend patients receive a ...

New blood clot guidelines for pregnant women

... based on the individual patient's thrombosis risk. The guidelines continue to recommend against the use of aspirin alone as a means to prevent venous thromboembolism in any patient population because more effective methods are available. ...

Patch Form of HRT Poses Less Clotting Risks Than Pill Does

... of therapy. Scarabin and his colleagues reviewed data from eight observational studies and nine randomized controlled trials on HRT and venous thromboembolism (VTE), a potentially fatal blood clot in the vein. Pool results indicated that the risk of VTE was 2.5 times higher in women taking oral estrogen ...

National Quality Forum Endorses Consensus Standards for Quality of Hospital Care

... opportunity for benchmarking to peers in the marketplace." Six of the measures target the most common preventable cause of hospital death -- venous thromboembolism (VTE). There are 900,000 cases of VTE in the United States every year, and a stunning 300,000 of them are fatal. Annually, over 600,000 of those ...

M. D. Anderson nurses find empowerment in PACTs

... have been resolved or closed. Since they were established, PACTs have tackled nursing issues that include developing a nursing-driven venous thromboembolism (VTE) assessment, a better pain assessment tool and a program to reduce the risk of calls among outpatients; clarifying instruction on the care of ...

Sanofi-aventis: Encouraging First-Quarter 2008 Results Further Positive Phase III Results for Eplivanserin

... three geographic regions. Lovenox(R) was approved in January in Japan and launched in April. The product is indicated for the prevention of venous thromboembolism (VTE) in patients undergoing orthopedic surgery of the lower limbs such as total hip replacement, total knee replacement and hip fracture surgery. ...

Methamphetamine Use Associated With Pulmonary Arterial Hypertension in Patients With Previously Unknown Risk Factors

... when other more common causes of pulmonary hypertension such as severe emphysema, interstitial lung disease, heart failure and chronic pulmonary thromboembolism have been ruled out. Idiopathic pulmonary arterial hypertension (IPAH) refers to PAH that occurs without a known cause and is extremely rare. PAH can ...

LA BioMed researcher says 'unexpected' increase in cancer risk found

... Further analysis showed that women taking the two hormones had higher risks of cardiovascular disease, coronary heart disease, stroke and venous thromboembolism and lower risks of fracture and colorectal cancer. About the Follow-Up Study After stopping intervention, WHI followed the trial ...

Blood Clots in Legs, Lungs Predispose Patients to Repeat Episodes

... venous thrombosis compared with patients with isolated deep vein thrombosis," the study authors noted. "However, rates of recurrent venous thromboembolism and major bleeding after deep vein thrombosis and pulmonary embolism remain unacceptably high in the community setting. Efforts are needed to ...